发布求助
文献互助 智能选刊 最新文献

JAMA最新文献

筛选
英文 中文
Corticosteroids for Sepsis, Acute Respiratory Distress Syndrome, or Community-Acquired Pneumonia 糖皮质激素治疗败血症、急性呼吸窘迫综合征或社区获得性肺炎
JAMA Pub Date : 2025-01-08 DOI: 10.1001/jama.2024.24537
Peggy B. Leung, Andrew M. Davis, Joshua Davis
{"title":"Corticosteroids for Sepsis, Acute Respiratory Distress Syndrome, or Community-Acquired Pneumonia","authors":"Peggy B. Leung, Andrew M. Davis, Joshua Davis","doi":"10.1001/jama.2024.24537","DOIUrl":"https://doi.org/10.1001/jama.2024.24537","url":null,"abstract":"This JAMA Clinical Guidelines Synopsis summarizes the 2024 Society of Critical Care Medicine guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescriptions and Reimbursement of Glucagon Products for Severe Hypoglycemia in Medicaid 医疗补助中治疗严重低血糖的胰高血糖素产品的处方和报销
JAMA Pub Date : 2025-01-08 DOI: 10.1001/jama.2024.25974
Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo
{"title":"Prescriptions and Reimbursement of Glucagon Products for Severe Hypoglycemia in Medicaid","authors":"Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo","doi":"10.1001/jama.2024.25974","DOIUrl":"https://doi.org/10.1001/jama.2024.25974","url":null,"abstract":"This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Effect of the Medicare Part D Redesign 评估医疗保险D部分重新设计的效果
JAMA Pub Date : 2025-01-08 DOI: 10.1001/jama.2024.25827
Rachel E. Sachs, Richard G. Frank
{"title":"Assessing the Effect of the Medicare Part D Redesign","authors":"Rachel E. Sachs, Richard G. Frank","doi":"10.1001/jama.2024.25827","DOIUrl":"https://doi.org/10.1001/jama.2024.25827","url":null,"abstract":"This Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Developments in Women’s Health Research at the US National Institutes of Health 美国国立卫生研究院妇女健康研究的最新进展
JAMA Pub Date : 2025-01-06 DOI: 10.1001/jama.2024.25878
Janine Austin Clayton, Diana W. Bianchi, Richard Hodes, Tara A. Schwetz, Monica Bertagnolli
{"title":"Recent Developments in Women’s Health Research at the US National Institutes of Health","authors":"Janine Austin Clayton, Diana W. Bianchi, Richard Hodes, Tara A. Schwetz, Monica Bertagnolli","doi":"10.1001/jama.2024.25878","DOIUrl":"https://doi.org/10.1001/jama.2024.25878","url":null,"abstract":"ImportanceThis article highlights key National Institutes of Health (NIH) programs, policies, and scientific advances that have informed and improved the health of women and describe the promise and potential of harnessing cutting-edge science and integrative approaches to advance women’s health research. Policy updates combined with recent scientific and programmatic initiatives are intended to expand understanding of women’s health, deliver diagnostics, and develop preventive approaches and novel therapies to meet critical health needs of contemporary women.ObservationsTo benefit all people through the work funded and conducted by the NIH biomedical research enterprise, NIH has implemented policies that broadly expanded the knowledge of human health and disease from the laboratory to the clinic. Historically, women’s health research initially focused on reproductive health and female-specific conditions. It has since expanded to encompass all aspects of the health of women. As new knowledge is generated, novel insights are uncovered about how diseases and conditions affect women uniquely, differently, or disproportionately and how sex and gender, as biological and social factors, respectively, influence health and disease at multiple levels. Although cutting-edge research has generated scientific advances leading to lifesaving vaccines, diagnostics, and treatments for women, many still do not have access to them. Thus, the White House announced an initiative that catalyzes innovative, integrative women’s health research and propels translation from basic science to practical benefits, improving outcomes for all women across the lifespan.Conclusions and RelevanceNIH’s policies, programs, and research funding fill gaps in knowledge about the health of women. Their synergistic results generate evidence for data-driven decision-making and targeted interventions that will improve the health not just of women, but of all people.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142929230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency Department Return Visits After Having Left Without Being Seen 在没有人看见的情况下离开急诊室后复诊
JAMA Pub Date : 2025-01-06 DOI: 10.1001/jama.2024.26825
Christopher S. Evans, Robert W. Turer, John J. Hanna, Emilie Pendley, Richard J. Medford
{"title":"Emergency Department Return Visits After Having Left Without Being Seen","authors":"Christopher S. Evans, Robert W. Turer, John J. Hanna, Emilie Pendley, Richard J. Medford","doi":"10.1001/jama.2024.26825","DOIUrl":"https://doi.org/10.1001/jama.2024.26825","url":null,"abstract":"This retrospective cohort study examines the incidence of return emergency department visits among patients who left without being seen at a prior index visit.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142929231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Researchers Compared Hospital Early Warning Scores for Clinical Deterioration—Here’s What They Learned 研究人员比较了医院临床恶化的早期预警评分，这是他们的研究结果
JAMA Pub Date : 2025-01-03 DOI: 10.1001/jama.2024.24062
Roy Perlis, Jennifer Abbasi
{"title":"Researchers Compared Hospital Early Warning Scores for Clinical Deterioration—Here’s What They Learned","authors":"Roy Perlis, Jennifer Abbasi","doi":"10.1001/jama.2024.24062","DOIUrl":"https://doi.org/10.1001/jama.2024.24062","url":null,"abstract":"This Medical News article is an interview with Dana P. Edelson, MD, MS, an expert in cardiac resuscitation at the University of Chicago and cofounder and chief medical officer of AgileMD, the company that makes the AI-driven early warning score software eCART.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142917620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024 1996-2024年对不同个体脉搏氧饱和度检测FDA指南的遵守
JAMA Pub Date : 2024-12-30 DOI: 10.1001/jama.2024.26473
Kadija Ferryman, Deidra C. Crews, Emmanuel F. Drabo, Theodore J. Iwashyna, Odia Kane, John W. Jackson
{"title":"Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024","authors":"Kadija Ferryman, Deidra C. Crews, Emmanuel F. Drabo, Theodore J. Iwashyna, Odia Kane, John W. Jackson","doi":"10.1001/jama.2024.26473","DOIUrl":"https://doi.org/10.1001/jama.2024.26473","url":null,"abstract":"This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil. 专家共识提供指南治疗脱发与低剂量口服米诺地尔。
JAMA Pub Date : 2024-12-27 DOI: 10.1001/jama.2024.25516
Samantha Anderer
{"title":"Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25516","DOIUrl":"https://doi.org/10.1001/jama.2024.25516","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"148 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza. 美国疾病控制与预防中心呼吁关注高危青少年流感患者抗病毒治疗使用不足。
JAMA Pub Date : 2024-12-27 DOI: 10.1001/jama.2024.25515
Samantha Anderer
{"title":"CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25515","DOIUrl":"https://doi.org/10.1001/jama.2024.25515","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Measles Cases Rose 20% in 1 Year as Vaccine Coverage Fell Short. 由于疫苗覆盖率不足，全球麻疹病例在一年内上升了20%。
JAMA Pub Date : 2024-12-27 DOI: 10.1001/jama.2024.25514
Samantha Anderer
{"title":"Global Measles Cases Rose 20% in 1 Year as Vaccine Coverage Fell Short.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25514","DOIUrl":"https://doi.org/10.1001/jama.2024.25514","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"699 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信